Skip to content
AnalystLens

CACI International Quarterly Report for Q1 Ended Sep 30, 2025

Filing Date
Filed October 23, 2025
Period End
September 30, 2025
Security
CACI
In the record · 2016–202610-K1110-Q338-K122

CACI filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 122 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’18May ’18
  2. Leadership change8-K · Jul ’20Jul ’20
  3. Leadership change8-K · Oct ’22Oct ’22
  4. Material agreement8-K · Dec ’24Dec ’24

Summary

Summary of the 10-Q filed October 23, 2025. Cited figures are marked; the original filing is the authoritative source.

CACI International Inc (CACI) reported results for the three months ended September 30, 2025, with revenues of $2,287,623 thousanda, up from $2,056,889 thousand a year earlier, and net income of $124,810 thousand compared with $120,177 thousand.

Diluted earnings per share were $5.63b versus $5.33. Income from operations rose to $212,275 thousand from $179,841 thousand, while interest expense and other, net increased to $46,173 thousand from $23,970 thousand, which management attributes primarily to higher outstanding debt balances. Management reports organic revenue growth of 5.5%, and total backlog of $33.9 billion, up 4.6% from $32.4 billion a year earlier.

Cash flow improved sharply: net cash provided by operating activities was $171,065 thousandc versus $34,661 thousand, driven by $53.6 million of higher earnings after non-cash adjustments and $82.8 million of net favorable working capital changes. Financing activities used $142,238 thousand as net borrowings declined, and total debt principal fell to $2,800,938 thousand from $2,942,625 thousand at June 30, 2025. Cash and cash equivalents increased to $133,020 thousand.

The filing also discloses an ongoing civil suit (Al Shimari) in which a jury reached a $42 milliond judgment against the Company in November 2024. The Company has appealed, the Court of Appeals heard oral argument on September 9, 2025, and no amounts have been recognized in the financial statements. Management describes the claims as completely without merit.

Key Highlights

  1. Revenue rose 11.2% to $2,287,623 thousand, with organic growth of 5.5% from new contract awards and growth on existing programs.
  2. Operating income increased 18.0% to $212,275 thousand; net income rose 3.9% to $124,810 thousand, and diluted EPS was $5.63 versus $5.33.
  3. Operating cash flow was $171,065 thousand versus $34,661 thousand a year earlier, and cash and cash equivalents ended the quarter at $133,020 thousand.
  4. Total backlog was $33.9 billion, up 4.6% from $32.4 billion a year earlier; remaining performance obligations were $13.1 billion, with approximately 44% expected to be recognized as revenue within 12 months.
  5. Total debt principal declined to $2,800,938 thousand from $2,942,625 thousand at June 30, 2025, following net repayments on the Revolving Facility and Term Loan.
  6. Interest expense and other, net rose 92.6% to $46,173 thousand, primarily due to higher outstanding debt balances.
  7. The Company faces a $42 million jury judgment in the Al Shimari civil suit, which is on appeal; no amounts have been recognized in the financial statements.

Financial Statements

Q1 FY2026 against Q1 FY2025

Line itemQ1 FY2026Q1 FY2025Change
Revenue$2.29B$2.06B+11.2%
SG&A Expenses$473.86M$427.95M+10.7%
Operating Expenses$2.08B$1.88B+10.6%
Operating Income$212.28M$179.84M+18.0%
Net Income$124.81M$120.18M+3.9%
EPS (Basic)$5.67$5.39+5.2%
EPS (Diluted)$5.63$5.33+5.6%
Shares Outstanding (Basic)21.99M22.30M−1.4%
Shares Outstanding (Diluted)22.17M22.54M−1.7%

Frequently Asked Questions

  1. How did CACI perform in the first quarter of fiscal 2026?

    Revenues increased 11.2% to $2,287,623 thousand, operating income rose 18.0% to $212,275 thousand, and net income grew 3.9% to $124,810 thousand. Diluted EPS was $5.63 compared with $5.33 a year earlier. The Company attributes the revenue increase partly to organic growth of 5.5%.

  2. What drove the improvement in operating cash flow?

    Net cash provided by operating activities increased $136.4 million to $171,065 thousand. Management cited $53.6 million of higher earnings after non-cash adjustments and $82.8 million of net favorable working capital changes, driven by decreased vendor disbursements.

  3. How is CACI's debt position changing?

    Total debt principal fell to $2,800,938 thousand at September 30, 2025 from $2,942,625 thousand at June 30, 2025. The Revolving Facility had no outstanding borrowings at quarter end. Interest expense and other, net increased to $46,173 thousand, which management attributes primarily to higher outstanding debt balances in the period. The Company stated it was in compliance with all financial covenants.

  4. What is the status of the Al Shimari litigation?

    A jury reached a $42 million judgment against the Company in November 2024. The District Court denied CACI's motion for judgment as a matter of law, and the Company appealed to the U.S. Court of Appeals, which heard oral argument on September 9, 2025. No amounts have been recognized in the financial statements, and the Company continues to believe the plaintiffs' position is completely without merit.

  5. What does the government funding environment mean for CACI?

    Management noted that the U.S. government entered a shutdown on October 1, 2025, and that the duration and future funding remain uncertain. The Company is continuing work on existing contracts funded by prior fiscal years' appropriations and mission essential programs. Management also cited the One Big Beautiful Bill Act, which provides approximately $156 billion in defense funding, including $25 billion for the Golden Dome initiative, available regardless of appropriations or shutdown status.